FY2018 · ended Dec 31, 2018 · Revenue $401,620, +312.7% YoY · Filed Mar 27, 2020
Kraig Biocraft Laboratories, Inc. (KBLB) files with the SEC under industry code 2820, Plastic Material, Synth Resin/Rubber, Cellulos (No Glass). Free cash flow was -$1.8 million. As of Jun 30, 2026 it held $3.4 million in cash and investments and $194,007 in total debt.
Revenue
$401,620
+312.7% vs prior year
Net income (TTM)
$-5.05M
+10.7% vs year-ago TTM
Operating cash flow (TTM)
$-2.04M
-18.8% vs year-ago TTM
Free cash flow (TTM)
$-2.08M
EPS
$0.00
Dividend per share
None
Shares outstanding
1.10B
+5.5% vs prior year
Net cash
$3.20M
as of Jun 30, 2026
Operating margin
-239.0%
FY 2018
Company profile
- Industry
- Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) (SIC 2820)
- Listed as
- KBLB (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- WY
- Headquarters
- Ann Arbor, MI
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1413119
- Former names
- Kraig Biocraft Laboratories, Inc (until May 20, 2025)
Other Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) companies
- Celanese Corp CE
- EIDP, Inc. CTA-PB
All 3 Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$3.4M | -$3.1M | -$2.6M | -$2.1M | -$2.8M |
| Net income | -$3.6M | -$3.4M | -$3.0M | -$3.8M | -$8.0M |
| Diluted EPS | $0.00 | $0.00 | $0.00 | — | — |
| Operating cash flow | -$1.8M | -$1.8M | -$1.2M | -$1.9M | -$1.8M |
| Free cash flow | -$1.8M | -$1.8M | -$1.3M | -$1.9M | -$1.9M |
| Total assets | $2.6M | $1.5M | $3.2M | $4.6M | $3.0M |
| Total liabilities | $10.6M | $9.7M | $8.9M | $8.1M | $8.3M |
| Stockholders' equity | -$8.0M | -$8.1M | -$5.7M | -$3.5M | -$5.3M |
| Cash and investments | $1.8M | $673,264 | $2.6M | — | — |
| Total debt | $171,162 | $87,474 | $96,157 | $59,897 | $104,124 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Feb 18, 2026 | Feb 18, 2026 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
All 384 Kraig Biocraft Laboratories, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.